# Hepatobiliary Tumors Tissue Samples Acquisition

> **NCT04445532** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Gallbladder Cancer
- Biliary Tract Cancer
- Liver Cancer
- Precancerous Condition
- Benign Hepatobiliary Disease
- Healthy, no Evidence of Disease

## Interventions

- **OTHER:** Gene expression analysis
- **OTHER:** Genomic analysis
- **OTHER:** Protein expression analysis
- **OTHER:** Proteomic profiling
- **OTHER:** Polymerase chain reaction
- **OTHER:** Mass spectrometry
- **OTHER:** Immunohistochemistry
- **OTHER:** Metabolomics profiling
- **OTHER:** Methylation and epigenetic analysis
- **OTHER:** Liquid biopsy analysis
- **OTHER:** Laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT04445532
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-11
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2023-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04445532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04445532, "Hepatobiliary Tumors Tissue Samples Acquisition". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04445532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*